← SynDRA
Hypoestoxide
SynDRA canonical compound SYN1970166 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | IKBKB | IL1B | IL6 | TNF |
|---|
| Mechanism of action | IKK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- (1R,3S,5S,8S,10S,12R,13S)-5,10,17,17-Tetramethyl-14-methylene-15-oxo-4,9-dioxatetracyclo[11.3.1.03,5.08,10]heptadecan-12-yl acetate
- [(1R,3S,5S,8S,10S,12R,13S)-5,10,17,17-tetramethyl-14-methylidene-15-oxo-4,9-dioxatetracyclo[11.3.1.03,5.08,10]heptadecan-12-yl] acetate
- Hypoestoxide,hypoestes rosea
- PD132594
Look up Hypoestoxide in the interactive SynDRA portal →